French company Delpharm to supply up to 51 million additional doses of the BioNTech/Pfizer vaccine

The European Medicines Agency (EMA) has validated the opening of additional manufacturing capacities for messenger RNA vaccines developed by Pfizer/BioNTech and Moderna against the coronavirus. The EMA's Committee for Medicinal Products for Human Use (CMUH) has thus approved a site in Saint-Rémy-sur-Avre (Eure-et-Loir) in France, intended for the manufacture of Comirnaty, the commercial name of the vaccine developed by BioNTech and Pfizer. The site, operated by the French group Delpharm, will supply up to 51 million additional doses of the vaccine this year, the EMA said.

source: https://www.ouest-france.fr/sante/virus/coronavirus/vaccins-anti-covid-l-ue-autorise-pfizer-et-moderna-a-duire-leurs-capacites-de-production- 58f32cfa-04ef-11ec-8432-332f83f8decd